Table 1 Challenges for effective treatment and vaccination of respiratory syncytial virus
From: Potential therapeutic implications of new insights into respiratory syncytial virus disease
Aim |
Prevent RSV bronchiolitis in infants under 6 months: |
Maternal of neonatal vaccination |
Passive antibody administration |
Studies are required: |
To identify factors that induce Th1 versus Th2 responses |
To gain an understanding of tolerance and immune suppression |
To gain an understanding the role of nonprotein antigens |
To control IgE responses |
To boost IgA responses |
To make practical improvements to DNA vaccination |
To develop new adjuvants |